4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Biodesix, Inc. (BDSX) operates in the Diagnostics & Research industry and is headquartered in Louisville, United States with about 334 employees. Its market capitalization is roughly $219 million. In the fiscal year ended 2025-12-31, BDSX reported $88M in revenue and ($35M) in net income.
Biodesix, Inc. operates as a diagnostic solutions company.
Interactive charts & full statements → Open the BDSX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $88M | $71M | $49M | $38M | — |
| Gross Profit | $72M | $56M | $36M | $24M | — |
| Operating Income (EBIT) | ($28M) | ($34M) | ($41M) | ($50M) | — |
| Net Income | ($35M) | ($43M) | ($52M) | ($65M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $26M | $29M | $22M | $20M | $18M | — |
| Gross Profit | $21M | $24M | $18M | $16M | $14M | — |
| Operating Income (EBIT) | ($6M) | ($2M) | ($7M) | ($10M) | ($9M) | — |
| Net Income | ($8M) | ($4M) | ($9M) | ($12M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $88M | $97M | $99M | $93M |
| Total Liabilities | $90M | $76M | $94M | $72M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BDSX viewer.
About TickerBase · Data methodology & sources